VTGN — VISTAGEN THERAPEUTICS INC

Ownership history in XTX Topco Ltd  ·  3 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in VISTAGEN THERAPEUTICS INC (VTGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2022 Q1)
Avg. % of fund
0.03%
First filed
2022 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 69,712 +901 +1.3% 0.01% $247K $3.55
2022 Q2 REDUCED 68,811 -22,755 -24.9% 0.02% $61K $26.40
2022 Q1 INITIATED 91,566 — — 0.05% $114K $37.20
% of Fund (quarterly)    VTGN price (monthly, adj. close)

Other funds also holding VTGN

As of 2025 Q4 — sorted by position size

LUMINUS MANAGEMENT LLC 3Y 7Y 0.2% TCG Crossover Management, LLC 3Y 0.06% ORBIMED ADVISORS LLC 3Y 7Y 0.04% Seven Fleet Capital Management LP 0.03% ADAR1 Capital Management, LLC 0.03% AdvisorShares Investments LLC 3Y 0.03% Ikarian Capital, LLC 3Y 0.03% STEMPOINT CAPITAL LP 0.02% Persistent Asset Partners Ltd 0.01% ADAR1 Capital Management, LLC 0.01%
← Back to XTX Topco Ltd Holdings